Genmab A/S (GNMSF) Net margin 2023–2025
Genmab A/S (GNMSF) net profit margin by fiscal year — reported net income divided by reported revenue.
25.9%FY2025 · since FY2023: 26.4% → 25.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 25.9% | -10.4 pp |
| FY2024 | 36.3% | +9.9 pp |
| FY2023 | 26.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GNMSF financial trends
GNMSF RevenueGNMSF Net incomeGNMSF Gross profitGNMSF Gross marginGNMSF Operating incomeGNMSF Operating marginGNMSF Operating cash flowGNMSF Free cash flowGNMSF Capital expendituresGNMSF Return on equityGNMSF Stock buybacksGNMSF Dividends paidGNMSF Total assetsGNMSF Total liabilitiesGNMSF Shareholders’ equityGNMSF overview →